Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Aurelio Cafaro & Barbara Ensoli. (2022) HIV-1 therapeutic vaccines in clinical development to intensify or replace antiretroviral therapy: the promising results of the Tat vaccine. Expert Review of Vaccines 21:9, pages 1243-1253.
Read now
Read now
Articles from other publishers (13)
Daniel Sepúlveda‐Crespo, María A. Jiménez‐Sousa, Amanda Fernández‐Rodíguez, María A. Muñoz‐Fernández, José L. Jiménez, Begoña B. Caraciolo, Sergio Reus Bañuls, Helem Vilchez, Beatriz Mothe, Isidoro Martínez, José M. Benito, Norma Rallón & Salvador Resino. (2023) IL7RA rs10491434 polymorphism is related to spontaneous HIV infection control in naïve HIV‐infected patients: A retrospective study. Journal of Medical Virology 95:11.
Crossref
Crossref
Svatava Snopková & Petr Husa. (2023) Implications of highly suppressive treatment HIV infection. Vnitřní lékařství 69:5, pages 289-292.
Crossref
Crossref
Daniel Sepúlveda‐Crespo, María A. Jiménez‐Sousa, Amanda Fernández‐Rodíguez, María A. Muñoz‐Fernández, José Luis Jiménez, Santiago Moreno, Felipe Garcia, Isidoro Martínez, José M. Benito, Norma Rallón & Salvador Resino. (2023)
IRF5‐TNOP3
polymorphisms are associated with elite control of HIV infection: A retrospective study
. Journal of Medical Virology 95:6.
Crossref
Crossref
Maryam Khan, Daniel Bradshaw, Colin S Brown, Jana Haddow, Poorvi Patel, Jennifer H C Tosswill, Katrina Pollock, Tamara Elliott, Xinzhu Wang, Jasmini Alagaratnam, Borja Mora-Peris, Steve Kaye, Myra O McClure, David Muir, Paul Randell, Graham P Taylor & Sarah J Fidler. (2023) Characterization of Rare Spontaneous Human Immunodeficiency Virus Viral Controllers Attending a National United Kingdom Clinical Service Using a Combination of Serology and Molecular Diagnostic Assays. Open Forum Infectious Diseases 10:5.
Crossref
Crossref
Omar Sued & Tomás M. Grosso. 2023. Viral Infections and Antiviral Therapies. Viral Infections and Antiviral Therapies
339
376
.
Chiara Stefani, Antonella Sangalli, Elena Locatelli, Tania Federico, Giovanni Malerba, Maria Grazia Romanelli, Gustavo Adolfo Argañaraz, Bosco Christiano Maciel Da Silva, Alberto Jose Duarte Da Silva, Jorge Casseb, Enrique Roberto Argañaraz, Alessandra Ruggiero & Donato Zipeto. (2022) Increased Prevalence of Unstable HLA-C Variants in HIV-1 Rapid-Progressor Patients. International Journal of Molecular Sciences 23:23, pages 14852.
Crossref
Crossref
Gennady Bocharov, Dmitry Grebennikov, Paula Cebollada Rica, Eva Domenjo-Vila, Valentina Casella & Andreas Meyerhans. (2022) Functional cure of a chronic virus infection by shifting the virus - host equilibrium state. Frontiers in Immunology 13.
Crossref
Crossref
Jenifer Masip, Norma Rallón, Elena Yeregui, Montserrat Olona, Salvador Resino, José M. Benito, Consuelo Viladés, Graciano García-Pardo, José Alcamí, Ezequiel Ruiz-Mateos, Frederic Gómez-Bertomeu, Montserrat Vargas, Marta Navarro, José A. Oteo, Juan A. Pineda, Anna Martí, Verónica Alba, Francesc Vidal, Joaquin Peraire & Anna Rull. (2022) Elevated α-Ketoglutaric Acid Concentrations and a Lipid-Balanced Signature Are the Key Factors in Long-Term HIV Control. Frontiers in Immunology 13.
Crossref
Crossref
Daniel Sepúlveda-Crespo, Norma Rallón, María José Muñoz-Gómez, Oscar Brochado-Kith, José Luis Jiménez, María Ángeles Muñoz-Fernández, José M. Benito & Salvador Resino. (2022) High Plasma sTNF-R1 Level Is Related to Loss of Natural HIV Control in Long-Term Elite Controllers. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Paulo D’Amora, Ismael Dale C. G. Silva, Maria Auxiliadora Budib, Ricardo Ayache, Rafaela Moraes Siufi Silva, Fabricio Colacino Silva, Robson Mateus Appel, Saturnino Sarat Júnior, Henrique Budib Dorsa Pontes, Ana Carolina Alvarenga, Emilli Carvalho Arima, Wellington Galhano Martins, Nakal Laurenço F. Silva, Ricardo Sobhie Diaz, Marcia B. Salzgeber, Anton M. Palma, Steven S. Evans & Robert A. Nagourney. (2021) Towards risk stratification and prediction of disease severity and mortality in COVID-19: Next generation metabolomics for the measurement of host response to COVID-19 infection. PLOS ONE 16:12, pages e0259909.
Crossref
Crossref
Ana-Irene Malo, Joaquim Peraire, Ezequiel Ruiz-Mateos, Jenifer Masip, Núria Amigó, José Alcamí, Santiago Moreno, Josefa Girona, Graciano García-Pardo, Rosaura Reig, Francesc Vidal, Antoni Castro, Lluís Masana & Anna Rull. (2021) Evolution of Serum Acute-Phase Glycoproteins Assessed by 1H-NMR in HIV Elite Controllers. Frontiers in Immunology 12.
Crossref
Crossref
Nathalia Beatriz Ramos De Sá, Karina dos S. Silva, Marcelo Ribeiro-Alves, Diogo Gama Caetano, Fernanda Heloise Côrtes, Suwellen S. D. de Azevedo, Brenda Hoagland, Beatriz Grinsztejn, Valdilea G. Veloso, Mariza G. Morgado & Sylvia Lopes Maia Teixeira. (2021) Killer immunoglobulin-like receptor (KIR) genes are associated with the risk of episodes of high-level and detectable viremia among HIV controllers. F1000Research 10, pages 546.
Crossref
Crossref
Isabella Zanella, Emanuele Focà, Melania Degli-Antoni, Francesco Castelli & Eugenia Quiros-Roldan. (2021) An HIV elite controller patient carrying the homozygous H63D variant in the homeostatic iron regulator gene. Medicine 100:45, pages e27732.
Crossref
Crossref